Sidoxia Capital Management, LLC
Position in HALO — Halozyme Therapeutics, Inc.
CIK 2132534
NEWPORT BEACH, CA
Position in HALO
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$3,205,313
+$958,904 QoQ
Shares Held
40,952
+17.8% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
3.51%
of 13F equity value
Holder Rank
#190
of 664 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Sidoxia Capital Management, LLC holds $5,776,914 across 2 Biotechnology names. HALO ranks #1 (55.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
This page
|
40,952 | $3,205,313 | |
| 2 | HRMY |
Harmony Biosciences Holdings, Inc.
|
70,629 | $2,571,601 |
All Filings in HALO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,205,313 | 40,952 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $2,246,409 | 34,758 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||